Amoxicillin-clavulanate therapy increases childhood nasal colonization by methicillin-susceptible Staphylococcus aureus strains producing high levels of penicillinase

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 12, 2004, Pages 4618-4623

  Guillemot, Didier ^b   Bonacorsi, Stephane ^c   Blanchard, John S ^a,f   Weber, Philippe ^e   Simon, Sylvie ^d   Guesnon, Bruno ^c   Bingen, Edouard ^c   Carbon, Claude ^d  

^a Unite des Agents Antibacteriens   (France)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d INSERM   (France)

^e Bio VSM   (France)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; METICILLIN; PENICILLIN G; PENICILLINASE;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; ENZYME SYNTHESIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NOSE SMEAR; PATIENT MONITORING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCREENING TEST;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; BETA-LACTAMS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; FRANCE; HUMANS; MALE; METHICILLIN; METHICILLIN RESISTANCE; NASAL CAVITY; PENICILLIN RESISTANCE; PENICILLINASE; PENICILLINS; RISK FACTORS; STAPHYLOCOCCUS AUREUS;

EID: 9644275463     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.12.4618-4623.2004     Document Type: Article

References (34)

1. Abudu, L., I. Blair, A. Fraise, and K. K. Cheng. 2001. Methicillin-resistant Staphylococcus aureus (MRSA): a community-based prevalence survey. Epidemiol. Infect. 126:351-356.
2. Barg, N., H. Chambers, and D, Kernodle. 1991. Borderline susceptibility to antistaphylococcal penicillins is not conferred exclusively by the hyperproduction of beta-lactamase. Antimicrob. Agents Chemother. 35:1975-1979.
3. Basker, M. J., R. A. Edmondson, and R. Sutherland. 1980. Comparative stabilities of penicillins and cephalosporins to staphylococcal beta-lactamase and activities against Staphylococcus aureus. J. Antimicrob. Chemother. 6:333-341.
4. Blazquez, J., M. R. Baquero, R. Canton, I. Alos, and F. Baquero. 1993. Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. Antimicrob. Agents Chemother. 37:2059-2063.
5. Chaibi, E. B., D. Sirot, G. Paul, and R. Labia. 1999. Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics. J. Antimicrob. Chemother. 43:447-458.
6. Chambers, H. F., and M. Sachdeva. 1990. Binding of beta-lactam antibiotics to penicillin-binding proteins in methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 161:1170-1176.
7. Comité de l'Antibiogramme de la Societé Française de Microbiologie. 1996. Zone sizes and MIC breakpoints for non-fastidious organisms. Clin. Microbiol. Infect. 2(Suppl. 1):S46-S49.
8. Ghaffar, F., L. S. Muniz, K. Katz, J. L. Smith, T. Shouse, P. Davis, and G. H. McCracken, Jr. 2002. Effects of large dosages of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, nonpneumococcal alpha-hemolytic streptococci, and Staphylococcus aureus in children with acute otitis media. Clin. Infect. Dis. 34:1301-1309.
9. Goering, R. V., and M. A. Winters. 1992. Rapid method for epidemiological evaluation of gram-positive cocci by field inversion gel electrophoresis. J. Clin. Microbiol. 30:577-580.
10. Hussein, F. M., S. Boyle-Vavra, and R. S. Daum. 2001. Community-acquired methicillin-resistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic. Pediatr. Infect. Dis. J. 20:763-767.
11. Isenberg, Henry D. (ed.). 1992. Clinical microbiology procedures handbook, vol. 1. American Society for Microbiology, Washington, D.C.
12. Kenner, J., T. O'Connor, N. Piantanida, J. Fishbain, B. Eberly, H. Viscount, C. Uyehara, and D. Hospenthal. 2003. Rates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population. Infect. Control Hosp. Epidemiol. 24:439-444.
13. Kernodle, D. S., D. C. Classen, C. W. Stratton, and A. B. Kaiser. 1998. Association of borderline oxacillin-susceptible strains of Staphylococcus aureus with surgical wound infections. J. Clin. Microbiol. 36:219-222.
14. Kirby, W. M. M. 1944. Extraction of a highly potent penicillin inactivator from penicillin resistant staphylococei. Science 99:452-453.
15. Kluytmans, J., A. van Belkum, and H. Verbrugh. 1997. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 10:505-520.
16. Kobayashi, S., S. Arai, S. Hayashi, and T. Sakaguchi. 1989. In vitro effects of beta-lactams combined with beta-lactamase inhibitors against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 33:331-335.
17. Lindenmayer, J. M., S. Schoenfeld, R. O'Grady, and J. K. Carney. 1998. Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch. Intern. Med. 158:895-899.
18. McDougal, L. K., and C. Thornsberry. 1986. The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins. J. Clin. Microbiol. 23:832-839.
19. McMurray, L. W., D. S. Kernodle, and N. L. Barg. 1990. Characterization of a widespread strain of methicillin-susceptible Staphylococcus aureus associated with nosocomial infections. J. Infect. Dis. 162:759-762.
20. Nakamura, M. M., K. L. Rohling, M. Shashaty, H. Lu, Y.-W. Tang, and K. M. Edwards. 2002. Prevalence of methicillin-resistant Staphylococcus aureus nasai carriage in the community pediatric population. Pediatr. Infect. Dis. J. 21:917-922.
21. Nannini, E. C., K. V. Singh, and B. E. Murray. 2003. Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue. Clin. Infect. Dis. 37:1194-1198.
22. Plorde, J. J., and J. C. Sherris. 1974. Staphylococcal resistance to antibiotics: origin, measurement, and epidemiology. Ann. N. Y. Acad. Sci. 236:413-434.
23. Rizwi, I., A. K. Tan, A. L. Fink, and R. Virden. 1989. Clavulanate inactivation of Staphylococcus aureus beta-lactamase: Biochem. J. 258:205-209.
24. Sa-Leao, R., I. S. Sanches, I. Couto, C. R. Alves, and H. de Lencastre. 2001. Low prevalence of methicillin-resistant strains among Staphylococcus aureus colonizing young and healthy members of the community in Portugal. Microb. Drug Resist. 7:237-245.
25. Salgado, C. D., B. M. Farr, and D. P. Calfee. 2003. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin. Infect. Dis. 36:131-139.
26. Salmenlinna, S., O. Lyytikinen, and J. Vuopio-Varkila. 2002. Community-acquired methicillin-resistant Staphylococcus aureus, Finland. Emerg. Infect. Dis. 8:602-607.
27. Selwyn, S. 1980. Comparative stabilities of penicillins and cephalosporins to staphylococcal beta-lactamase and activities against Staphylococcus aureus. J. Antimicrob. Chemother. 6:794-795.
28. Shopsin, B., B. Mathema, J. Martinez, E. Ha, M. L. Campo, A. Fierman, K. Krasinski, J. Kornblum. P. Alcabes, M. Waddington, M. Riehman, and B. N. Kreiswirth. 2000. Prevalence of methicillin-resistant and methicillin- susceptible Staphylococcus aureus in the community. J. Infect. Dis. 182:359-362.
29. Spink, W., and V. Ferris. 1945. Quantitative action of penicillin inhibitor from penicillin-resistant strains in staphylococci. Science 102:221.
30. Suggs, A. H., M. C. Maranan, S. Boyle-Vavra, and R. S. Daum. 1999. Methicillin-resistant and borderline methicillin-resistant asymptomatic Staphylococcus aureus colonization in children without identifiable risk factors. Pediatr. Infect. Dis. J. 18:410-414.
31. Vannuffel, P., J. Gigi, H. Ezzedine, B. Vandercam, M. Delmee, G. Wauters, and J. L. Gala. 1995. Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR. J. Clin. Microbiol. 33:2864-2867.
32. Vedel, G., A. Belaaouaj, L. Gilly, R. Labia, A. Philippen, P. Nevot, and G, Paul. 1992. Clinical isolates of Escherichia coli producing TRI beta-lactamases: novel TEM-enzymes conferring resistance to beta-lactamase inhibitors. J. Antimicrob. Chemother. 30:449-462.
33. Zierdt, C. H., I. K. Hosein, R. Shively, and J. D. MacLowry. 1992. Phage pattern-specific oxacillin-resistant and borderline oxacillin-resistant Staphylococcus aureus in U.S. hospitals: epidemiological significance. J. Clin. Microbiol. 30:252-254.
34. Zygmunt, D. J., C. W. Stratton, and D. S. Kernodie. 1992. Characterization of four beta-lactamases produced by Staphylococcus aureus. Antimicrob. Agents Chemother. 36:440-445.